Nevro Corp. (NVRO) SEC filings
NVRO SEC filings moved a median of -0.17% by the close. NVRO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NVRO overview →
35 measured NVRO SEC filing events.
Where these NVRO SEC filings landedvs 31 measured NVRO SEC filing reactions
| Middle 50% of NVRO SEC filing reactions | -5.81% to +0.87% |
|---|---|
| Median reaction (to close) | -0.17% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 NVRO SEC filing events with a measured close landed between -5.81% and +0.87%; 32% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K NEVRO CORP For: Apr 01 | SEC filing · Form 8-K | — | — | |
| Form POS AM NEVRO CORP | SEC filing · Form POS | — | — | |
| Form S-8 POS NEVRO CORP | SEC filing · Form S-8 | — | — | |
| Form 8-K NEVRO CORP For: Apr 02 | SEC filing · Form 8-K | — | — | |
| Form DEFA14A NEVRO CORP | SEC filing · Form DEFA14A | +0.00% | +0.00% | |
| Form DEFM14A NEVRO CORP | SEC filing · Form DEFM14A | +0.79% | +1.05% | |
| Form 10-K NEVRO CORP For: Dec 31 | SEC filing · Form 10-K | +0.35% | +0.87% | |
| Form 8-K NEVRO CORP For: Mar 04 | SEC filing · Form 8-K | +0.35% | +0.87% | |
| Form PREM14A NEVRO CORP For: Feb 21 | SEC filing · Form PREM14A | +0.00% | -0.35% | |
| Form DEFA14A NEVRO CORP | SEC filing · Form DEFA14A | +0.00% | +0.00% | |
| Form 8-K NEVRO CORP For: Feb 06 | SEC filing · Form 8-K | -0.52% | -0.17% | |
| Form DEFA14A NEVRO CORP | SEC filing · Form DEFA14A | -0.52% | -0.17% | |
| Form 8-K NEVRO CORP For: Jan 13 | SEC filing · Form 8-K | -0.47% | -2.38% | |
| Form 8-K NEVRO CORP For: Nov 11 | SEC filing · Form 8-K | -0.73% | +10.78% | |
| Form 10-Q NEVRO CORP For: Sep 30 | SEC filing · Form 10-Q | -3.50% | -24.70% | |
| Form 10-Q NEVRO CORP For: Jun 30 | SEC filing · Form 10-Q | -4.20% | -7.82% | |
| Form 8-K NEVRO CORP For: Jun 30 | SEC filing · Form 8-K | -4.20% | -7.82% | |
| Form S-8 NEVRO CORP | SEC filing · Form S-8 | -4.20% | -7.82% | |
| Form SD NEVRO CORP | SEC filing · Form SD | -0.11% | +1.08% | |
| Form 8-K NEVRO CORP For: May 23 | SEC filing · Form 8-K | -0.64% | -1.50% | |
| Form 8-K NEVRO CORP For: May 05 | SEC filing · Form 8-K | -0.85% | -7.55% | |
| Form 10-Q NEVRO CORP For: Mar 31 | SEC filing · Form 10-Q | -1.86% | -12.11% | |
| Form 8-K NEVRO CORP For: May 07 | SEC filing · Form 8-K | -1.86% | -12.11% | |
| Form 8-K NEVRO CORP For: Apr 22 | SEC filing · Form 8-K | -0.35% | -1.99% | |
| Form DEF 14A NEVRO CORP For: Apr 12 | SEC filing · Form DEF | +0.31% | -4.07% | |
| Form DEFA14A NEVRO CORP | SEC filing · Form DEFA14A | +0.31% | -4.07% | |
| Form 10-K NEVRO CORP For: Dec 31 | SEC filing · Form 10-K | +1.42% | +3.51% | |
| Form S-8 NEVRO CORP | SEC filing · Form S-8 | +1.42% | +3.51% | |
| Form 8-K NEVRO CORP For: Feb 21 | SEC filing · Form 8-K | +10.71% | +12.31% | |
| Form EFFECT NEVRO CORP | SEC filing · Form EFFECT | -1.01% | -7.60% | |
| Form 8-K NEVRO CORP For: Jan 06 | SEC filing · Form 8-K | -0.14% | +0.14% | |
| Form S-3 NEVRO CORP | SEC filing · Form S-3 | -0.96% | -2.45% | |
| Form 8-K NEVRO CORP For: Nov 30 | SEC filing · Form 8-K | +12.59% | +9.16% | |
| Form 10-Q NEVRO CORP For: Sep 30 | SEC filing · Form 10-Q | +1.87% | +0.00% | |
| Form 8-K NEVRO CORP For: Nov 01 | SEC filing · Form 8-K | +1.87% | +0.00% |
Keep exploring
More NVRO: earnings → · analyst actions → · NVRO overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Avalon GloboCare Corp. (AVCO) | 254 | 0.00% | 41% |
| Editas Medicine, Inc. (EDIT) | 253 | -1.15% | 39% |
| DarioHealth Corp. (DRIO) | 252 | 0.00% | 45% |
| Cue Biopharma, Inc. (CUE) | 251 | -0.05% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.